Sébastien Papot

18PUBLICATIONS
18CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPredictive and prognostic markersBiomaterialsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Dec 31, 2025
An Enzyme-Responsive Imiquimod Prodrug for Precision Immune Activation within the Tumor Microenvironment.

Elsa Cannoni, Israa Al Jamal, Rony Eid

|Dec 29, 2025
A β-Glucuronidase-Responsive Albumin-Binding Prodrug of a Potent Focal Adhesion Kinase Inhibitor for Targeted Cancer Therapy.

Louna Mossino, Rémi Châtre, Mélanie Poinsot

|Jan 21, 2025
β-Glucuronidase-Responsive Albumin-Binding Prodrug of Colchicine-Site Binders for Selective Cancer Therapy.

Alexandra Bordes, Isabelle Opalinski, Fabien Thoreau

|Jul 02, 2024
An Enzyme-Responsive Self-Immolative Recognition Marker for Manipulating Cell-Cell Interactions.

Chad Plumet, Spyridon D Katsakos, Mélissa Girard

|Aug 14, 2023
Combination of Targeted Therapies for Colorectal Cancer Treatment.

Elodie Péraudeau, Brigitte Renoux, Sheik Emambux

|Jul 05, 2023
VOC-Based Probes, a New Set of Analytical Tools to Monitor Patient Health from Blood Sample. Proof of Concept on Tracking COVID-19 Infection.

Estelle Blochouse, Rony Eid, Nahla Araji

Pageof 3

Frequent Collaborators

5 joint publications

Pauline Poinot

2 joint publications

Jeanne Crassous

1 joint publications

Sergii Kolodych

1 joint publications

Alain Wagner